Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 18, 2013
Clinical News
All-In-One: Clinical trial started
...Minn.) markets Resolute Integrity, a zotarolimus-eluting coronary stent utilizing the BioLinx polymer, to treat CAD.
Svelte Medical Systems Inc.
...
Read More
BioCentury
|
Nov 14, 2011
Clinical News
All-In-One update
...Svelte began the DIRECT trial to evaluate its All-In-One stent system in 30 patients.
Svelte Medical Systems Inc.
...
Read More
BioCentury
|
Nov 14, 2011
Company News
Svelte Medical Systems, Royal DSM deal
...is in a first-in-man clinical trial to treat coronary artery lesions. Details were not disclosed.
Svelte Medical Systems Inc.
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Feb 18, 2013
Clinical News
All-In-One: Clinical trial started
...Minn.) markets Resolute Integrity, a zotarolimus-eluting coronary stent utilizing the BioLinx polymer, to treat CAD.
Svelte Medical Systems Inc.
...
Read More
BioCentury
|
Nov 14, 2011
Clinical News
All-In-One update
...Svelte began the DIRECT trial to evaluate its All-In-One stent system in 30 patients.
Svelte Medical Systems Inc.
...
Read More
BioCentury
|
Nov 14, 2011
Company News
Svelte Medical Systems, Royal DSM deal
...is in a first-in-man clinical trial to treat coronary artery lesions. Details were not disclosed.
Svelte Medical Systems Inc.
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page